Advertisement
Screener

Edwards Lifesciences Corporation (EW) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

2.9 / 5 stars · 70/120 Roast Me

Edwards Lifesciences Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

Edwards Lifesciences Corporation (EW) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 1.40 million shares for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-28.

Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2014-02-28

  • Edwards Lifesciences Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2011-12-31 was 0.00 shares.
  • Edwards Lifesciences Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2011-09-30 was 0.00 shares.
  • Edwards Lifesciences Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2013 was 1.40M shares, a 27.27% increase from fiscal 2012.
  • Edwards Lifesciences Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2012 was 1.10M shares, a 0.00% change from fiscal 2011.
  • Edwards Lifesciences Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2011 was 1.10M shares, a 35.29% decline from fiscal 2010.
  • Edwards Lifesciences Corporation share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2010 was 1.70M shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month
2013-12-311.40M shares
10-K · filed 2014-02-28
2012-12-311.10M shares
10-K · filed 2013-02-28
2011-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27
0.00 shares
derived: sum of 2 quarters · filed 2012-02-27
1.10M shares
10-K · filed 2012-02-27
2011-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
1.10M shares
10-Q · filed 2011-11-08
2011-06-301.10M shares
10-Q · filed 2011-08-08
2010-12-311.70M shares
10-K · filed 2011-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
STERIS plc (STE)Ireland$20.343B25.49
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00